维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：作者名="Fallahi P"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Thyroid involvement in hepatitis C-associated mixed cryoglobulinemia显示文摘	Fallahi P Ferrari SM Giuggioli D	2014	Hormones(Athens)2014，13，1：	1
2	Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis 显示文摘	Antoelli A Ferri C Fallahi P	2007	Eur J Endocrinol2007，156，4：	1
3	Prevalence of thyroid dysfunctions in systemic lupus erythematosus 显示文摘	Antonelli A Fallahi P Mosca M	2010	Metabolism2010，59，6：	1
4	dynamic scheduling in flexible job shop systems by considering simultane- ously efficiency and stability 显示文摘	Fattahi P Fallahi A	2010	Journal of Manufacturing 2cience and Technology2010，2，2：	1
5	High levels of circulating CXC chemol~ine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism显示文摘	Antonelli A Rotondi M Fallahi P	2004	J Clin Endocfinol Metab2004，89，11：	1
6	Aspirin insensitive thrombophil-ia :transcript profiling of blood identifies platelet abnormalities andHLA restriction 显示文摘	Fallahi P Katz R Toma I	2013	Gene2013，520，2：	1
7	New therapies for dedifferentiated papillary thyroid cancer显示文摘	FALLAHI P MAZZI V VITA R	2015	Int J Mol Sci2015，16，：	1
8	Prevalence of thyroid dysfunctions in systemic lupus erythematosus显示文摘	Antonelli A Fallahi P Mosca M	2010	Metabolism2010，59，：	1
9	Personalization of targeted therapy in advanced thyroid cancer显示文摘	FALLAHI P FERRARI S M MAZZI V	2014	Curr Genomics2014，15，：	1
10	Congenital chole- dochal cyst in an infant with cystic fibrosis 显示文摘	Tabatabaie P Fallahi GH Farahmand F	2009	Ann Hepato2009，8，2：	1
11	Thyroid disorders in chronic hepatitis C virus infection显示文摘	Antonelli A Ferri C Fallahi P	2006	Thyroid2006，16，：	1
12	CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenie properties, is active against primary anaplastic thyroid cancer in vitro and in vivo显示文摘	Antonelli A Bocci G Fallahi P	2014	J Clin Endoerinol Metab2014，99，4：	1
13	RET TKI:potential role in thyroid cancers 显示文摘	Antonelli A Fallahi P Ferrari SM	2012	Curt Oncol Rep2012，14，2：	1
14	Iodine-131 given for thera-peutic purposes modulates differently interferon-γ-inducible α-che-mokine CXCL10 serum levels in patients with active Graves'dis-ease or toxic nodular goiter显示文摘	Antonelli A Rotondi M Fallahi P	2007	J Clin Endocrinol Metab2007，92，4：	1
15	Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer显示文摘	Antonelli A Miccoli P Fallahi P		0，，：	1
16	New therapies for dadifferentiatad papillary thyroid cancer显示文摘	Fallahi P Mazzi V Vita R	2015	Int J Mol Sci2015，16，3：	1
17	Monitoring and adaptive control of C02 laser flame cutting 显示文摘	Fallahi Sichani E De Keuster J Kruth J P	2010	Physics Procedia2010，5，：	1
18	Increase of interferon-gamma inducible alpha chemokine CXCL10but not beta chemokine CCL2serum levels in chronic autoimmune thyroiditis显示文摘	Antonelli A Rotondi M Fallahi P	2005	Eur J Endocrinol2005，152，2：	1
19	Sorafenib and Thyroid Cancer显示文摘	Fallahi P Ferrari SM Santini F	2013	BioDrugs2013，27，6：	1
20	Serum levels of the inter-feron-γ-inducible a chemokine CXCL10 in patients with active Graves'disease,and modulation by methimazole therapy and thy-roidectomy显示文摘	Antonelli A Fallahi P Rotondi M	2006	British J Surg2006，93，10：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示